12:00 AM
Feb 27, 2012
 |  BC Week In Review  |  Company News  |  Other News

Aveo Pharmaceuticals, Astellas cancer news

Aveo Pharmaceuticals Inc. (NASDAQ:AVEO), Cambridge, Mass.
Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan
Business: Cancer
The National Comprehensive Cancer Network (NCCN) received a $2 million grant from Aveo and...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >